The effectiveness of a vaccine against #HIV

29 October 2021

Dr Behazine Combadière, a lead investigator at the Centre for Immunology and Infectious Diseases @INSERM is working on predicting the effectiveness of a vaccine against #HIV which is concurrently advancing the #CovidVaccine development research.

Know more

Residency and trafficking of ILC2 under stable and Th2-induced inflammatory conditions

Location : webinar Speaker : Maxime Petit (CIMI-paris)
Know more

TBC

Location : webinar Speaker : Amélie Guihot (CIMI-paris)
Know more

TBC

Location : webinar Speaker : Bruno Stankoff (Professor of Neurology (UPMC))
Know more

Is it dangerous to be vaccinated if you have already had the coronavirus?

24 August 2021

A message received by the editorial staff of LCI.fr is concerned about the possible danger of a vaccine against Covid-19 for people already infected. We respond with Béhazine Combadière, director of research at Inserm.

Know more

Scientist and Christian: where is the problem?

Location : webinar Speaker : Philippe Deterre (retired CIMI-paris)
Know more

Covid-19: a needle-free vaccination soon possible?

24 August 2021

To meet the demand for vaccines, and to avoid a possible shortage of needles and syringes, start-ups, with the support of certain countries such as Canada, are working on injection methods that are not intramuscular, but through the skin.

Know more

Human pathogenic fungus Candida albicans

Location : webinar Speaker : Allon Weiner (CIMI-paris)
Know more

SARS-CoV2 and T cell response

Location : webinar Speaker : Lucille Adam (CIMI-paris)
Know more

Particularly active antibodies as a barrier to SARS-CoV-2

24 August 2021

Teams from the Pitié-Salpêtrière AP-HP hospital, Sorbonne University, Inserm and the Pasteur Institute have carried out work to study the role played by IgA-type antibodies in protecting the body against Covid-19 in the mucous membranes, particularly the respiratory tract.

Know more